We have launched our mobile app, get it now. Call : 9354229384, 9354252518, 9999830584.  

Current Affairs

Diabetes drug shows promise on Covid-19 lung effects

Date: 16 June 2021 Tags: Miscellaneous

Issue

Studies have shown that metformin drug used in diabetes treatment has the ability to reduce lung inflammation in mice infected with SARS CoV-2 virus.

 

Background

The drug, metformin, is used in early therapy for diabetes type-2 condition as it can lower sugar in blood.

 

Details

  • The researchers from University of California San Diego (UCSD) were studying the anti-inflammatory mechanism showed by the metformin drug in mice models.

  • To check the efficacy of the drug, they selected mice showing acute respiratory distress syndrome (ARDS). In this condition, fluids leak into the lungs and causes difficulty in breathing.

  • The acute respiratory distress syndrome (ARDS) was a major reason for death of patients admitted in hospitals due to Covid-19 infection.

  • The mice were administered metformin drug before or after exposure to the bacteria that caused pneumonia.

  • The drug was able to restrict the onset of symptoms of acute respiratory distress syndrome (ARDS) and reduce pulmonary inflammation. Mortality rate also decreased significantly.